Andrea Coravos

CEO/Co-founder at HumanFirst, Research Collaborator at Harvard-MIT Center for Regulatory Science

Andrea Coravos: Co-founder and CEO of HumanFirst, Acquired by ICON plc

Andrea Coravos is the co-founder and CEO of HumanFirst, a company recently acquired by ICON plc, a leading provider of drug development solutions and services.1 HumanFirst is focused on enabling precision measures in clinical research.1

Key Facts about Andrea Coravos::

Co-founder and CEO of HumanFirst, which was acquired by ICON plc in 20244
Former Entrepreneur in Residence at the FDA in the Digital Health Unit2
Previously worked as a software engineer at Instacart and Akili Interactive, a leader in digital medicine2
Held positions at KKR Capstone and McKinsey, focusing on healthcare, energy, and financial industries2
Duke University graduate, digital rights advocate, and Taylor Swift fan2
Occasional writer on her blog and Google Scholar2
Active on Twitter as @AndreaCoravos5

In a recent article for Intelligent Health, Coravos shared insights on leveraging digital health technologies and wearables to manage chronic conditions, drawing from her Lancet Digital Health review.3 6

Highlights

Jul 31 · x.com

ICON Plc - X.com

Nov 21 · Forbes

It’s Time For ‘Nutrition Labels’ In Artificial Intelligence - Forbes

Sep 28 · Yahoo Finance

Insights From HumanFirst Show Breadth of Pharmaceutical Investment in AI/ML and Digital Endpoints in Clinical Trials - Yahoo Finance

Experience

CEO/Co-founder at HumanFirst since April 2017

Research Collaborator at Harvard-MIT Center for Regulatory Science since July 2018; Former Investor (Angel Track) at First Round Capital in 2022, Advisor for Biohacking Village at DEF CON until 2022; Entrepreneur In Residence at FDA from January 2018 to March 2019, Software Engineer internships at Akili Interactive Labs, Inc. from August 2016 to January 2017; Instacart from June 2016 to August 2016